BIOCOLLECTIVE, LLC

Denver, CO · Founded 2015 · Biotech · Private

Microbiome Reference Standards (MRS) — characterized, homogeneous microbial community samples for quality control and validation in microbiome research and diagnostics

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Biotech
Headquarters
Denver, CO
Founded
2015
Latest Form D
$1M, Sep 2017
Total capital
$2.5M
Federal grants
$1.1M
3 awards · 2019–2021
Rank in peer group#29 of 32
Private capital raised
$1.4M
3 Form D · last Sep 2017
110 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

2015201620172018201920202021FEDERAL ↑EQUITY ↓Cumulative $2.5M$147K$763K$199K1st Form D$250K2nd Form D$90K3rd Form D$1M
2015201720192021FEDERAL ↑EQUITY ↓Cumulative $2.5M$147K$763K$199K3rd Form D$1M

Latest events

  • Federal grantHealth and Human S · Phase II · Reference standards for quality control and data validation in microbiome studies$199K
  • Federal grantHealth and Human S · Phase II · Reference standards for quality control and data validation in microbiome studies$763K
  • Federal grantHealth and Human S · Phase II · Reference standards for quality control and data validation in microbiome studies$147K
  • Private capital raisedForm D · SEC · 3rd filing$1M
  • Private capital raisedForm D · SEC · 2nd filing$90K
  • Private capital raisedForm D · SEC · 1st filing$250K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 32 peers

Line = median

Biotech · Instrument

  • Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Martha R. CarlinExecutive Officer, DirectorNamed in SEC Form D filings
  • Matha R. CarlinExecutive Officer, Director, PromoterNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .